{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260420339813/en/Tozorakimab-met-primary-endpoint-in-Phase-III-MIRANDA-trial-in-patients-with-COPD", "message": "News view counter 671033 successfully enlarged"}